The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer

International Journal of Radiation Biology

Volumn 73, Issue 6, 1998, Pages 699-704

  Santin, A D ^a,b   Hermonat, P L ^a   Ravaggi, A ^a,b   Chiriva Internati, M ^a,b   Hiserodt, J C ^c   Batchu, R B ^a   Pecorelli, S ^b   Parham, G P ^a  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; DOSE RESPONSE; GAMMA IRRADIATION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; PRIORITY JOURNAL; RADIATION DOSE; UTERINE CERVIX CANCER;

ANTIGENS, NEOPLASM; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031875116     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530098141951     Document Type: Article

References (40)

1. ABDEL-WAHAB, Z., DAR, M. M., HESTER, D., VERVAERT, C., GANGAVALLI, R., BARBER, J., DARROW, T. L. and SEIGLER, H. F., 1996, Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene modified melanima cells. Cellular Immunology, 171, 246-254.
2. ALEXANDER, M., SALGALLER, M. L., CELIS, E., SETTE, A., BARNES, W. A., ROSENBERG, S. A. and STELLER, M. A., 1996, Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. American Journal Obstetrics and Gynecology, 175, 1586-1593.
3. ANDERSON, S. L., SHEN, T., LOU, J., XING, L., BLACHERE, N. E., SRIVASTAVA, P. K. and RUBIN, B. Y., 1994, The endoplasmic reticular heat shock protein gp96 is transcriptionally upregulated in interferon-treated cells. Journal of Experimental Medicine, 180, 1565-1569.
4. BLACHERE, N. E., UDONO, H., JANETZKI, S., LI, Z., HEIKE, M. and SRIVASTAVA, P. K., 1993, Heat shock protein vaccines against cancer. Journal of Immunotherapy, 14, 352-360.
5. BRINTON, L. A., 1992, Epidemiology of cervical cancer: overview. In The Epidemiology of Human Papillomaiirus and Central Cancer, edited by N. Munoz, F. Bosh, K. V. Shah and A. Meheus (Lyon, France: IARC Science Publications), No. 119, pp. 3-23.
6. CHEX, L., THOMAS, E. K., HU, S.-L., HELLSTROM, I. and HELLSTROM, K. E., 1991, Human papilloma virus type 16 nucleoprotein E7 is a tumor rejection antigen. Proceedings of the National Academy of Sciences, USA, 88, 110-114.
7. CONNOR, M. E. and STERN, P. L., 1990, Loss of MHC Class-I expression in cervical carcinomas. International Journal of Cancer, 46, 1029-1034.
8. DAVIDOFF, A. M., IGLEHART, J. D. and MARKS, J. R., 1992, Immune respose to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proceedings of the National Academy of Sciences, U S A, 89, 3439-3442.
9. DELEO, A. B., BECKER, M. and LAW, L. W., 1993, Properties of a Mr 110,000 tumor rejection antigen of chemically induced BALB/c Meth A sarcoma. Cancer Research, 53, 1602-1607.
10. DISAIA, P. J. and CREASMAN, W. T., 1993, Epithelial cervical cancer. In Clinical Gynecologic Oncology, edited by P. J. DiSaia and W. T. Creasman (St Louis, MO: Mosby Year Book), pp. 1-36.
11. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACSON, Y., HAMADA, H., PARDOLL, D. and MULLIGAN, C. R., 1993, Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proceedings of the National Acadamy of Sciences, USA, 90, 3539-3543.
12. FUJEDA, S., NODA, I., SAITO, H., HOSHINO, T. and YAGITA, M., 1995, Heat shock enhances the susceptibility of tumor cells to lysis by lymphokine-activated killer cells. Archives of Otolaryngolog - Head Neck Surgery, 121, 1009-1014.
13. HALL, E. J., 1988, Time, dose, and fractionation in radiotherapy. In Radiobiology for the Radiologist, third edition (Philadelphia, PA: JB Lippincott Company), pp. 239-259.
14. HAREYAMA, M., IMAI, K., KUBO, K., TAKAHASHI, H., KOSHIBA, H., HINODA, Y., SHIDOU, M., OOUCHI, A., YACHI, A. and KAZUO, M., 1991, Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells. Cancer, 67, 2269-2274.
15. b in B16 melanoma cells. Cancer Research, 53, 1952-1955.
16. HONMA, S., TSUKADA, S., HONDA, S., NAKAMURA, M., TAKAKUWA, K. and MARUHASHI, T., 1994, Biological - clinical significance of selective loss of HLA-class I allelic product expression in squamous-cell carcinoma of the uterine cervix. International Journal of Cancer, 57, 650-655.
17. HUANG, A. Y. C., GOLUMBEK, P., AHMADZADEH, M., JAFFEE, E., PARDOLL, D. and LEVITSKY, H., 1994, Role of bone-marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science, 264, 961-965.
18. KINLEN, L. J., SHEIL, A. G. R., PETO, J. and DOLL, R., 1979, Collaborative United Kingdom - Australian study of cancer in patients treated with immunosuppressive drugs. British Medical Journal, 2, 1461-1466.
19. LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of bacteriophage T4. Nature, 227, 680-685.
20. LIANG, X. H., VOLKMANN, M., KLEIN, R., HERMAN, B. and LOCKETT, S. J., 1993, Co-localization of the tumor suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene, 8, 2645-2652.
21. MANARA, G. C., SANSONI, P., BADIALI-DE GIORGI, L., GALLINELLA, G., FERRARI, C., BRIANTI, V., FAGNONI, F. F., RUEGG, C. L., DE PANFILIS, G. and PASQINELLI, G., 1993, New insights suggesting a possible role of a heat shock protein 70-kD family-related protein in antigen processing/presentation phenomenon in humans. Blood, 82, 2865-2871.
22. MANIATIS, T., FRITSCH, E. F. and SAMBROOK, J., 1982, Journal of Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory).
23. MATSUMOTO, H., WANG, X. and OHNISHI, T., 1995, Binding between wild-type p53 and hsp72 accumulated after UV and γ-ray irradiation. Cancer Letters, 92, 127-133.
24. MCFADDEN, G. and KANE, K., 1994, How DNA viruses perturb functional MHC expression to alter immune recognition. Advancement in Cancer Research, 63, 117-209.
25. MENEGUZZI, G., CERNI, C., KIENY, M. P. and LATHE, R., 1991, Immunization against human papilloma virus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology, 181, 62-69.
26. OBOSHI, S., SHIMOSATO, Y., ITAKURA, K. and UMEGAKY, S., 1967a, Radiation pathology for cancer: I. Changes in histopathological finding during radiotherapy. Igakunoayumi, 61, 655-671.
27. OBOSHI, S., SHIMOSATO, Y., ITAKURA, K. and UMEGAKY, S., 1967b, Radiation pathology for cancer: II. The immunological significance of the infiltration of lymphocytes surrounding the tumor tissue during irradiation. Igakunoayumi, 61, 725-730.
28. PENN, I., 1988, Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer, 58, 611-616.
29. RELLIHAN, M. A., DOOLEY, D. P. and BURKE, T. W., 1990, Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecologic Oncology, 36, 435-438.
30. SANTIN, A. D., HERMONAT, P. L., HISERODT, J. C., CHIRIVAINTERNATI, M., WOODLIFF, B. A., THEUS, J. W., BARCLAY, D., PECORELLI, S. and PARHAM, G. P., 1997, Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion/costimulation molecules ICAM-1 in human cervical cancer. International Journal Radiation Oncology, Biology, Physics, 39, 737-742.
31. SANTIN, A. D., IOLI, G. R., HISERODT, J. C., et al., 1995, Development and characterization of an IL-4 secreting human ovarian carcinoma cell line. Gynecologic Oncology. 58, 230-239.
32. SCHLESINGER, M. J., TISSIERES, A. and ASHBURNER, M., editors, 1982, Heat Shock Proteins: From Bacteria to Man (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory).
33. SEPEHRNJA, B., PAZ, I. B., DASGUPTA, G. and MOMAND, J., 1996, Heat Shock Protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment on the cells. Journal of Biololy and Chemistry, 25, 15 084-15090.
34. SRIVASTAVA, P. K., 1993, Peptide-binding heat shock proteins in the endoplasmatic reticulum: role in the immune response to cancer and in antigen presentation. Advancement in Cancer Research, 62, 153-177.
35. SRIVASTAVA, P. K., DELEO, A. and Old, L., 1986, Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proceedings of the National Academy of Sciences, USA, 83, 3407-3411.
36. TOWBIN, H., STAEHELIN, T. and GORDON, J., 1979, Electrophoretic transfer of protein from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U S A, 76, 4350-4354.
37. WEI, Y., ZHAO, X., KARIYA, Y., FUKATA, H., TESHIGAWARA, K. and UCHIDA, A., 1996, Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvment of γδ T cells and heat shock protein 70. Cancer Research, 56, 1104-1110.
38. YAMASHITA, T., MIZUKOSHI, T., TOMITA, K. and KOBAYASHI, H., 1987, Anti-tumor immunity and tumor metastases by the influence of irradiation dosage in local radiotherapy. Gann no Rinsho, 33, 1205-1210.
39. YANG, E. K., RADOMINSKA, A., WINDER, B. S. and DANNENBERG, A. J., 1993, Dietary lipids coinduce xenobiotic metabolizing enzymes in rat liver. Biochimic Biophysic Acta, 1168, 52-58.
40. YEE, C., KRISHHNAN-HEWLETT, I., BACKER, C. C., SCHLEGEL, R. and HOWLEY, P. M., 1985, Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. American Journal of Pathology, 119, 361-366.